Trial
NCT06046287
Daratumumab for Polyneuropathy Associated With MGUS
Phase IIWITHDRAWNOPERATIONALConfidence: HIGH
Sponsor
Georgetown University
Collaborators
Janssen, LP
Condition
Peripheral Neuropathy
Intervention
Daratumumab and hyaluronidase-fihj
Why stopped
Lack of accrual
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2025-10-01